Key statistics
As of last trade, Microbot Medical Inc (MBOT:NAQ) traded at 0.9173, 11.87% above the 52 week low of 0.82 set on Sep 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9173 |
---|---|
High | 0.9173 |
Low | 0.9173 |
Bid | 0.9101 |
Offer | 0.95 |
Previous close | 0.9254 |
Average volume | 81.39k |
---|---|
Shares outstanding | 16.50m |
Free float | 16.26m |
P/E (TTM) | -- |
Market cap | 15.27m USD |
EPS (TTM) | -0.81 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 14:30 BST.
More ▼
- Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
- Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
- Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
- Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
- Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
- Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
- Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
- Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
More ▼